Weiss Ratings Reiterates Hold (C) Rating for Keurig Dr Pepper (NASDAQ:KDP)

Key Points

• Weiss Ratings has reiterated a "hold" (C) rating for Keurig Dr Pepper (NASDAQ:KDP), signaling a cautious approach from analysts.
• Analyst target prices for Keurig Dr Pepper shares have been revised down by firms like Citigroup and BNP Paribas, indicating a consensus price target of $35.00.
• Despite challenges, Keurig Dr Pepper reported a 6.1% increase in quarterly revenue year-over-year, matching earnings expectations with $0.49 EPS for the quarter.

Keurig Dr Pepper (NASDAQ:KDP - Get Free Report)'s stock had its "hold (c)" rating reiterated by stock analysts at Weiss Ratings in a report issued on Wednesday,Weiss Ratings reports.

Several other analysts have also weighed in on the stock. Citigroup decreased their target price on shares of Keurig Dr Pepper from $41.00 to $37.00 and set a "buy" rating on the stock in a research report on Tuesday, September 16th. BNP Paribas downgraded Keurig Dr Pepper from a "neutral" rating to an "underperform" rating in a report on Monday, September 22nd. Piper Sandler dropped their target price on Keurig Dr Pepper from $40.00 to $35.00 and set an "overweight" rating for the company in a report on Wednesday, September 17th. Hsbc Global Res lowered Keurig Dr Pepper from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, August 26th. Finally, Wells Fargo & Company lowered their price target on Keurig Dr Pepper from $40.00 to $33.00 and set an "overweight" rating on the stock in a research report on Thursday, September 25th. Eleven research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $35.00.

Keurig Dr Pepper Price Performance

Shares of NASDAQ:KDP opened at $25.58 on Wednesday. The firm has a market capitalization of $34.75 billion, a PE ratio of 22.84, a PEG ratio of 1.39 and a beta of 0.43. The company has a current ratio of 0.64, a quick ratio of 0.40 and a debt-to-equity ratio of 0.56. Keurig Dr Pepper has a 1-year low of $25.03 and a 1-year high of $37.27. The business's 50 day moving average is $29.67 and its 200-day moving average is $32.36.

Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last issued its earnings results on Thursday, July 24th. The company reported $0.49 EPS for the quarter, hitting the consensus estimate of $0.49. The firm had revenue of $4.16 billion during the quarter, compared to analysts' expectations of $4.14 billion. Keurig Dr Pepper had a return on equity of 11.05% and a net margin of 9.75%.Keurig Dr Pepper's quarterly revenue was up 6.1% compared to the same quarter last year. During the same period last year, the business earned $0.45 earnings per share. Sell-side analysts predict that Keurig Dr Pepper will post 1.92 earnings per share for the current year.

Insider Buying and Selling at Keurig Dr Pepper

In other Keurig Dr Pepper news, Director Robert James Gamgort sold 7,601 shares of the stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $35.91, for a total transaction of $272,951.91. Following the sale, the director owned 2,284,568 shares of the company's stock, valued at $82,038,836.88. This represents a 0.33% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Mary Beth Denooyer sold 12,000 shares of the business's stock in a transaction dated Thursday, July 17th. The stock was sold at an average price of $33.66, for a total transaction of $403,920.00. Following the completion of the transaction, the insider directly owned 82,511 shares of the company's stock, valued at approximately $2,777,320.26. This represents a 12.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 435,601 shares of company stock worth $14,421,512 in the last 90 days. Company insiders own 0.40% of the company's stock.

Institutional Trading of Keurig Dr Pepper

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Park Avenue Securities LLC bought a new position in Keurig Dr Pepper in the 1st quarter valued at $251,000. Farther Finance Advisors LLC lifted its stake in shares of Keurig Dr Pepper by 122.1% during the first quarter. Farther Finance Advisors LLC now owns 8,771 shares of the company's stock valued at $307,000 after acquiring an additional 4,822 shares during the period. Yousif Capital Management LLC boosted its holdings in Keurig Dr Pepper by 4.5% in the first quarter. Yousif Capital Management LLC now owns 150,933 shares of the company's stock valued at $5,165,000 after acquiring an additional 6,525 shares during the last quarter. GAMMA Investing LLC boosted its holdings in Keurig Dr Pepper by 23.2% in the first quarter. GAMMA Investing LLC now owns 9,963 shares of the company's stock valued at $341,000 after acquiring an additional 1,879 shares during the last quarter. Finally, SG Americas Securities LLC increased its position in Keurig Dr Pepper by 1,553.0% in the first quarter. SG Americas Securities LLC now owns 334,034 shares of the company's stock worth $11,431,000 after purchasing an additional 313,826 shares during the period. Institutional investors and hedge funds own 93.99% of the company's stock.

About Keurig Dr Pepper

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.